Company intelligence / Profile preview

Qingdao Zhixin Health Technology

Qingdao, Shandong, Chinamedchemexpress.com ↗

Ownership: Private
Development stage: Other

Overview

Qingdao Zhixin Health Technology Co., Ltd. appears to be an active Chinese healthcare technology and medical device company involved in supporting or sponsoring early-stage clinical research, particularly related to diabetes. The company has been listed as a sponsor for interventional studies investigating metabolic and cardiovascular effects of drugs such as mirabegron and moxifloxacin in diabetic populations. There are no public records of approved drugs or devices directly attributed to this entity.

Therapeutic areas: Endocrinology
Industry: Contract Research Organization

Beyond the preview

Go deeper on Qingdao Zhixin Health Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingdao Zhixin Health Technology.

Explore the full profile